EUVIMEDEUVIMED entdecken
Crossref

Anticancer Properties of Hexosamine Analogs Designed to Attenuate Metabolic Flux through the Hexosamine Biosynthetic Pathway

Christopher T Saeui, Sagar R Shah, Beatriz I Fernandez-Gil iD, Cissy Zhang, Christian Agatemor, Kris Dammen-Brower iD, Mohit P Mathew, Matthew Buettner, Prateek Gowda iD, Pratik Khare, Andrea Otamendi-Lopez, Shuang Yang iD und 4 weitere

ACS Chemical Biology · 2023

DOI: 10.1021/acschembio.2c00784 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ACS Chemical Biology, 2023. Verfasst von Christopher T Saeui und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedical Engineering and The Translational Tissue Engineering Center, The Johns Hopkins University and Johns Hopkins School of Medici…. Hauptthemen laut MEDLINE: Pancreatic Neoplasms, Antineoplastic Agents. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 90 Literaturangaben. Gefördert von: National Cancer Institute, Florida Department of State, National Heart, Lung, and Blood Institute.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Pancreatic NeoplasmsAntineoplastic AgentsAnimalsBiosynthetic PathwaysHexosaminesGlucoseUridine DiphosphateAcetylglucosamine

Substanzen

HexosaminesAntineoplastic AgentsGlucoseUridine DiphosphateAcetylglucosamine

Autor:innen und Institutionen

  • Department of Biomedical Engineering and The Translational Tissue Engineering Center, The Johns Hopkins University and Johns Hopkins School of Medicine, Baltimore, Maryland 21231, United States.
  • Department of Neurosurgery, Mayo Clinic, Jacksonville, Florida 32224, United States.
  • Department of Oncology, Johns Hopkins School of Medicine, Baltimore, Maryland 21205, United States.
  • Department of Chemical and Biomolecular Engineering, The Johns Hopkins University, Baltimore, Maryland 21205, United States.
  • Department of Pathology, Johns Hopkins School of Medicine, Baltimore, Maryland 21287, United States.

ORCID-Profile: Beatriz I Fernandez-Gil, Kris Dammen-Brower, Prateek Gowda, Shuang Yang, Hui Zhang, Kevin J Yarema

Förderung

  • National Cancer Institute
  • Florida Department of State
  • National Heart, Lung, and Blood Institute
  • Office of the Director
  • Mayo Clinic
  • University of Florida
  • Florida Center for Tumor Research
  • Sol Goldman Pancreatic Cancer Research Center, Johns Hopkins University School of Medicine

Zitieren

APA

Saeui, C. T., Shah, S. R., Fernandez-Gil, B. I., Zhang, C., Agatemor, C., Dammen-Brower, K., Mathew, M. P., Buettner, M., Gowda, P., Khare, P., Otamendi-Lopez, A., Yang, S., Zhang, H., Le, A., Quinoñes-Hinojosa, A., & Yarema, K. J. (2023). Anticancer Properties of Hexosamine Analogs Designed to Attenuate Metabolic Flux through the Hexosamine Biosynthetic Pathway. ACS Chemical Biology. https://doi.org/10.1021/acschembio.2c00784

Vancouver

Saeui CT, Shah SR, Fernandez-Gil BI, Zhang C, Agatemor C, Dammen-Brower K, et al. Anticancer Properties of Hexosamine Analogs Designed to Attenuate Metabolic Flux through the Hexosamine Biosynthetic Pathway. ACS Chemical Biology. 2023. doi:10.1021/acschembio.2c00784

BibTeX
@article{Saeui2023,
  author = {Saeui, Christopher T and Shah, Sagar R and Fernandez-Gil, Beatriz I and Zhang, Cissy and Agatemor, Christian and Dammen-Brower, Kris and Mathew, Mohit P and Buettner, Matthew and Gowda, Prateek and Khare, Pratik and Otamendi-Lopez, Andrea and Yang, Shuang and Zhang, Hui and Le, Anne and Quinoñes-Hinojosa, Alfredo and Yarema, Kevin J},
  title = {Anticancer Properties of Hexosamine Analogs Designed to Attenuate Metabolic Flux through the Hexosamine Biosynthetic Pathway},
  journal = {ACS Chemical Biology},
  year = {2023},
  doi = {10.1021/acschembio.2c00784}
}
Kostenlos starten →